AstraZeneca’s Alexion takes NMOSD awareness campaign long-form in new film highlighting community
Lights, camera, Alexion! Fresh off earning FDA approval for its drug Ultomiris to treat certain adults with neuromyelitis optica spectrum disorder, AstraZeneca’s rare disease unit has put out a short film sharing several NMOSD patients’ stories—and …